SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037631
Filing Date
2022-11-14
Accepted
2022-11-14 16:22:59
Documents
63
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mtcr-10q_20220930.htm   iXBRL 10-Q 2657915
2 EX-31.1 mtcr-ex311_7.htm EX-31.1 22430
3 EX-31.2 mtcr-ex312_8.htm EX-31.2 21437
4 EX-32.1 mtcr-ex321_6.htm EX-32.1 14176
  Complete submission text file 0001564590-22-037631.txt   8110966

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20220930.xsd EX-101.SCH 54825
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtcr-20220930_cal.xml EX-101.CAL 42244
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtcr-20220930_def.xml EX-101.DEF 156637
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20220930_lab.xml EX-101.LAB 446841
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20220930_pre.xml EX-101.PRE 317657
57 EXTRACTED XBRL INSTANCE DOCUMENT mtcr-10q_20220930_htm.xml XML 1233129
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39512 | Film No.: 221385978
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences